Stockscreener 앱 받기
2.73
16.06%
-0.32
전일 마감가:
$3.05
열려 있는:
$2.97
하루 거래량:
127.67K
Relative Volume:
0.13
시가총액:
$2.42M
수익:
$3.29M
순이익/손실:
$-3.09M
주가수익비율:
-2.2195
EPS:
-1.23
순현금흐름:
$-2.46M
1주 성능:
-34.10%
1개월 성능:
-32.87%
6개월 성능:
-60.28%
1년 성능:
-74.65%
1일 변동 폭
$2.65
$3.30
1주일 범위
$2.65
$4.00
52주 변동 폭
$1.92
$13.97
Nanovibronix Inc Stock (NAOV) Company Profile
명칭
Nanovibronix Inc
전화
(914) 233-3004
주소
969 PRUITT AVE,, TYLER
NAOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
2.65 | 2.42M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
131.54 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.99 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.10 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.56 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.75 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Nanovibronix Inc 주식(NAOV)의 최신 뉴스
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia - BioSpace
NanoVibronix expands distribution in Australia after study - Investing.com India
Healthcare Breakthrough: NanoVibronix Secures National Australian Distribution for UroShield Device - Stock Titan
NanoVibronix, Inc. SEC 10-K Report - TradingView
Why Nanovibronix Inc. (NAOV) Surged On Thursday? - MSN
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
NanoVibronix Inc (NASDAQ: NAOV) Gains 55.49% In Early Trade; What Lies Ahead? - stocksregister.com
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 - MSN
NanoVibronix (NAOV) Stock Is Skyrocketing: What's Going On? - Benzinga India
NanoVibronix (NAOV) Stock Surges In Pre-Market Trading Following A Positive Study - Stocks Telegraph
Top Premarket Gainers -March 17, 2025 at 07:39 am EDT - Marketscreener.com
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India
NanoVibronix announces UroShield health service study data published - TipRanks
NanoVibronix’s UroShield Study Published in Medical Journal - TipRanks
Breakthrough Study: Medical Device Slashes UTI Rates by 86% and Cuts Healthcare Costs - StockTitan
NanoVibronix announces reverse stock split - Medical Buyer
NanoVibronix announces reverse stock split By Investing.com - Investing.com Australia
NanoVibronix Announces 1-for-11 Reverse Stock Split - Nasdaq
NanoVibronix stock hits 52-week low at $0.3 amid market challenges - Investing.com
NanoVibronix stock hits 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix Announces Reverse Stock Split - citybiz
Nanovibronix announces reverse stock split - Marketscreener.com
NanoVibronix 1:11 Reverse Split Launches March 14Key Details for Shareholders - StockTitan
NanoVibronix shareholders approve reverse stock split By Investing.com - Investing.com South Africa
NanoVibronix shareholders approve reverse stock split - Investing.com
NanoVibronix stock plunges to 52-week low at $0.36 - Investing.com
NanoVibronix stock plunges to 52-week low at $0.36 By Investing.com - Investing.com Nigeria
NanoVibronix files to sell shares of Series G Convertible Preferred Stock, warrants - MSN
Oncolytics Biotech receives Nasdaq non-compliance notice - MSN
NanoVibronix Completes Merger with ENvue Medical Holdings - TipRanks
NanoVibronix Acquires ENvue Medical Holdings To Expand Medical Device Market Reach - Nasdaq
FDA Approves MED-EL’s Sonnet 3 Audio Processor for Cochlear Implants - MPO-mag
NanoVibronix Acquires Enteral Feeding Company ENvue - MPO-mag
NanoVibronix Acquires ENvue Medical Holdings - citybiz
NanoVibronix acquires enteral tech firm ENvue Medical - MSN
NanoVibronix Completes ENvue Medical Acquisition -February 14, 2025 at 10:54 am EST - Marketscreener.com
NanoVibronix completes acquisition of ENvue Medical - TipRanks
NanoVibronix acquires enteral tech firm ENvue Medical By Investing.com - Investing.com UK
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. - WICZ
Strategic Medical Tech Acquisition: NanoVibronix Takes Over Enteral Feeding Pioneer ENvue - StockTitan
Ascendis Pharma targets €200M SKYTROFA revenue and expands YORVIPATH globally in 2025 - MSN
Ocean Biomedical reports unregistered equity sales - MSN
IMUNON names Douglas Faller as chief medical officer - MSN
Pilot Phase Ends for NanoVibronix’s UroShield Study - MPO-mag
NanoVibronix Provides Year-End Business Update - ACCESS Newswire
NanoVibronix Announces Presentation of PainShield(R) to HCPCS Workgroup at CMS - ACCESS Newswire
NAOV’s 2023 Market Dance: Down -23.05% – Time to Invest? - The InvestChronicle
In the Green: MKDWELL Tech Inc (MKDW) Closes at 0.37, Up/Down -20.43 from Previous Day - The Dwinnex
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Nanovibronix Inc (NAOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.69%
0.15%
자본화:
|
볼륨(24시간):